Picture of Cumberland Pharmaceuticals logo

CPIX Cumberland Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Cumberland Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3.55-3.42-3.6-5.65-6.33
Depreciation
Deferred Taxes
Non-Cash Items0.7030.531-2.84-1.672.85
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.433.538.1810.44.63
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities3.065.426.348.456.09
Capital Expenditures-1.02-2.11-0.354-2.07-0.453
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3.320.356-0.147-11.60.347
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities2.3-1.76-0.502-13.7-0.106
Financing Cash Flow Items-0.086-1.76-2.17-2.21-3.27
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-5.08-7.12-3.55-2.06-7.42
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.274-3.462.29-7.28-1.44